Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Dose Escalation and Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma

This study has been completed.
Sponsor:
Information provided by:
Pain Therapeutics
ClinicalTrials.gov Identifier:
NCT00734188
First received: August 12, 2008
Last updated: July 12, 2011
Last verified: July 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2010
  Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)